FACTOR VII DEFICIENCY

FACTOR VII DEFICIENCY was reported 67 times

FACTOR VII DEFICIENCY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 SLAMF7-directed Immunostimulatory Antibody [EPC] 5 0.0010
1 CD38-directed Cytolytic Antibody [EPC] 5 0.0009
2 Enzyme Stabilizer [EPC] 1 0.0009
3 Antifibrinolytic Agent [EPC] 6 0.0006
4 Vitamin K [EPC] 5 0.0006
5 Skin Test Antigen [EPC] 1 0.0005
6 Glucosylceramide Synthase Inhibitor [EPC] 1 0.0004
7 Angiotensin Converting Enzyme Inhibitor [EPC] 14 0.0001
8 Proteasome Inhibitor [EPC] 10 0.0001
9 Nitrofuran Antibacterial [EPC] 1 0.0001
10 Thiazide Diuretic [EPC] 11 0.0001
11 Angiotensin 2 Receptor Blocker [EPC] 15 0.0000
12 beta-Adrenergic Blocker [EPC] 14 0.0000
13 Dihydropyridine Calcium Channel Blocker [EPC] 15 0.0000
14 P2Y12 Platelet Inhibitor [EPC] 5 0.0000
15 Nucleoside Metabolic Inhibitor [EPC] 9 0.0000
16 Loop Diuretic [EPC] 14 0.0000
17 Nitroimidazole Antimicrobial [EPC] 2 0.0000
18 Platinum-based Drug [EPC] 8 0.0000
19 Aminoglycoside Antibacterial [EPC] 1 0.0000
20 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
21 Alkylating Drug [EPC] 5 0.0000
22 Macrolide Antimicrobial [EPC] 1 0.0000
23 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
24 Nonsteroidal Anti-inflammatory Drug [EPC] 15 0.0000
25 Central Nervous System Stimulant [EPC] 1 0.0000
26 Platelet Aggregation Inhibitor [EPC] 6 0.0000
27 Antiarrhythmic [EPC] 1 0.0000
28 Thalidomide Analog [EPC] 5 0.0000
29 Mood Stabilizer [EPC] 2 0.0000
30 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
31 Corticosteroid [EPC] 10 0.0000
32 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
33 Vitamin C [EPC] 3 0.0000
34 Vitamin D [EPC] 2 0.0000
35 Vitamin B12 [EPC] 2 0.0000
36 Anti-epileptic Agent [EPC] 1 0.0000
37 Benzodiazepine [EPC] 2 0.0000
38 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
39 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
40 Proton Pump Inhibitor [EPC] 1 0.0000